Rekombinanter HLA-DRA Antikörper
Kurzübersicht für Rekombinanter HLA-DRA Antikörper (ABIN7828289)
Target
Alle HLA-DRA Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Recombinant HLA-DRA Monoclonal Antibody
-
Aufreinigung
- Protein A purified
-
Immunogen
- Recombinant human HLA-DRA fragment
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
- IHC 1:50-1:100,FCM 1:50
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Andere Bezeichnung
- HLA-DRA
-
Hintergrund
- HLA-DRA,HLA-DRA1,major histocompatibility complex,class II,DR alpha,DR alpha chain,DR alpha chain precursor,DRA,DRB1,DRB4,Histocompatibility antigen HLA DR alpha,HLA class II histocompatibility antigen,HLA class II histocompatibility antigen DR alpha chain,HLA DR1B,HLA DR3B,HLA DRA,HLA DRA1,HLA DRB1,HLA DRB3,HLA DRB4,HLA DRB5,HLADR4B,HLADRA1,HLADRB,Major histocompatibility complex class II DR alpha,Major histocompatibility complex class II DR beta 1,Major histocompatibility complex class II DR beta 3,Major histocompatibility complex class II DR beta 4,Major histocompatibility complex class II DR beta 5,MGC117330,MHC cell surface glycoprotein,MHC class II antigen DRA,MHC II,MLRW,An alpha chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the beta chain HLA-DRB, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DR-restricted CD4-positive T cells. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [
-
UniProt
- P01903
-
Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-